Add-on Acquisition • Life Science

ABclonal Biotechnology Acquires Yurogen Biosystems

On March 5, 2021, ABclonal Biotechnology acquired life science company Yurogen Biosystems

Acquisition Context

This is ABclonal Biotechnology’s 1st transaction in the Life Science sector.
This is ABclonal Biotechnology’s 1st transaction in the United States.
This is ABclonal Biotechnology’s 1st transaction in Massachusetts.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	March 5, 2021
Target	Yurogen Biosystems
Sector	Life Science
Buyer(s)	ABclonal Biotechnology
Deal Type	Add-on Acquisition

Target Company

Yurogen Biosystems

Worcester, Massachusetts, United States

Yurogen Biosystems LLC is a contract research organization (CRO) dedicated to monoclonal antibody discovery in biopharma and biotech sectors. Yurogen Biosystems was founded in 2014 and is based in Worcester, Massachusetts.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

ABclonal Biotechnology

Wuhan, China

Category	Company
Sector	Life Science

DESCRIPTION

ABclonal Biotechnology is a global life science tools and services provider. ABclonal Biotechnology was founded in 2011 and is based in Wuhan, China.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Massachusetts	1 of 1
Country: United States	1 of 1
Year: 2021	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Massachusetts M&A - United States M&A - 2021 M&A